Altimmune (ALT) FCF Margin Growth (5y) (2015 - 2025)
Altimmune (ALT) FCF Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.42 Mn |
| Sep 30, 2025 | -23.76 Mn |
| Jun 30, 2025 | -38.68 Mn |
| Mar 31, 2025 | -33.66 Mn |
| Dec 31, 2024 | -36.50 Mn |
| Sep 30, 2024 | -54.20 Mn |
| Jun 30, 2024 | -36.20 Mn |
| Mar 31, 2024 | -32.71 Mn |
| Dec 31, 2023 | -4.45 Mn |
| Sep 30, 2023 | -561,461.00 |
| Jun 30, 2023 | -32.30 Mn |
| Mar 31, 2023 | -9.25 Mn |
| Dec 31, 2022 | -6.64 Mn |
| Sep 30, 2022 | -75.54 Mn |
| Jun 30, 2022 | -20.88 Mn |
| Mar 31, 2022 | -4.12 Mn |
| Dec 31, 2021 | -54,039.00 |
| Sep 30, 2021 | -1.11 Mn |
| Jun 30, 2021 | -1.92 Mn |
| Mar 31, 2021 | -270,271.00 |